Table 3. Clinical characteristics of 29 patients with kinase fusions.
| Age (years) | |
| Median | 8.8 |
| Range | 1.9–16 |
| WBC count | |
| Median (× 103/μl) | 94.2 |
| Range | 0.6–420 |
| Sex | |
| Male | 22 |
| Female | 7 |
| NCI | |
| SR | 8 |
| HR | 21 |
| PSL response | |
| PGR | 16 |
| PPR | 13 |
| Induction failure | |
| Yes | 4 |
| No | 25 |
| Allo-HSCT in first CR | |
| Yes | 10 |
| No | 19 |
| Outcome | |
| Alive | 21 |
| Dead | 8 |
Abbreviations: allo-HSCT, allogeneic hematopoietic stem cell transplantation; CR, complete remission; HR, high risk; NCI, National Cancer Institute; PGR, prednisolone good responder; PPR, prednisolone poor responder; PSL, prednisolone; SR, standard risk; WBC, white blood cell.